Point72 Asia (Singapore) Pte. Ltd. Tg Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 10,166 shares of TGTX stock, worth $237,782. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,166
Previous 23,746
57.19%
Holding current value
$237,782
Previous $361 Million
49.93%
% of portfolio
0.04%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$320 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$266 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$157 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$85.3 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$75.9 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.4B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...